Meetings - The ASCO Post

This is Part 3 of Later-Line Considerations in Relapsed/Refractory Renal Cell Carcinoma, a three-part video roundtable series. Scroll down to watch the other videos from this roundtable. In this vid...

kidney cancer

/ Later-Line Considerations in Relapsed Refractory Renal Cell Carcinoma

Refractory RCC After Disease Progression on Adjuvant IO Therapy

This is Part 2 of Later-Line Considerations in Relapsed/Refractory Renal Cell Carcinoma, a three-part video roundtable series. Scroll down to watch the other videos from this roundtable. In this vid...

kidney cancer

/ Later-Line Considerations in Relapsed Refractory Renal Cell Carcinoma

Metastatic Favorable-Risk RCC After Progression on VEGF/IO Therapy

This is Part 1 of Later-Line Considerations in Relapsed/Refractory Renal Cell Carcinoma, a three-part video roundtable series. Scroll down to watch the other videos from this roundtable. In this vid...

Later-Line Considerations in Relapsed Refractory Renal Cell Carcinoma

Metastatic RCC After Disease Progression on VEGF/IO Therapy

Refractory RCC After Disease Progression on Adjuvant IO Therapy

Metastatic Favorable-Risk RCC After Progression on VEGF/IO Therapy

Pediatric AML Comparison of Induction Regimens

Older Patients With Newly Diagnosed Hodgkin Lymphoma Preexisting Heart Failure and Survival Outcomes

Cancer Screening Rates May Be Significantly Lower in US Federally Qualified Health Centers

Aspirin Use Among Breast Cancer Survivors: Navigating Negative Results, Age, and Health Equity

Propofol Exposure and Neurocognitive Outcomes in Children With High-Risk ALL